Human diseases with underlying defects in chromatin structure and modification.

Chromatin structure is important for regulating gene expression and for the proper condensation and segregation of chromosomes during cell division. Several human genetic diseases have been found to be due to mutations in genes producing proteins known or suspected to be involved in maintaining or modifying chromatin structure. Here we describe these 'chromatin diseases' and review what is known about the associated chromatin proteins in light of recent advances in the understanding of chromatin components, modification and function.

[1]  A. Bird,et al.  Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins , 1998, Molecular and Cellular Biology.

[2]  N. Tommerup,et al.  Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene , 1999, Nature.

[3]  Matthias Merkenschlager,et al.  Association of Transcriptionally Silent Genes with Ikaros Complexes at Centromeric Heterochromatin , 1997, Cell.

[4]  K. Zhao,et al.  MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. , 2001, Human molecular genetics.

[5]  F. Jeanmougin,et al.  A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. , 1996, The EMBO journal.

[6]  R. W. Miller,et al.  Tumors in Rubinstein-Taybi syndrome. , 1995, American journal of medical genetics.

[7]  H. Zoghbi,et al.  Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. , 1999, American journal of human genetics.

[8]  J. Gécz,et al.  Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. , 1994, Human molecular genetics.

[9]  N. C. Schanen,et al.  Neonatal Encephalopathy in Two Boys in Families With Recurrent Rett Syndrome , 1998, Journal of child neurology.

[10]  M. Renz,et al.  The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. , 1995, Arthritis and rheumatism.

[11]  J. Jeddeloh,et al.  Maintenance of genomic methylation requires a SWI2/SNF2-like protein , 1999, Nature Genetics.

[12]  Diagnostic criteria for rett syndrome , 1988 .

[13]  J. Herman,et al.  Promoter-region hypermethylation and gene silencing in human cancer. , 2000, Current topics in microbiology and immunology.

[14]  J. Chelly,et al.  Two affected boys in a Rett syndrome family , 2000, Neurology.

[15]  T. Kouzarides,et al.  Dnmt3a binds deacetylases and is recruited by a sequence‐specific repressor to silence transcription , 2001, The EMBO journal.

[16]  E. Hoffman,et al.  MeCP2 mutations in children with and without the phenotype of Rett syndrome , 2001, Neurology.

[17]  A. Bird,et al.  Active Repression of Methylated Genes by the Chromosomal Protein MBD1 , 2000, Molecular and Cellular Biology.

[18]  C. Wijmenga,et al.  Genetic variation in ICF syndrome: Evidence for genetic heterogeneity , 2000, Human mutation.

[19]  K. Robertson,et al.  The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. , 1999, Nucleic acids research.

[20]  A. Wolffe,et al.  How does DNA methylation repress transcription? , 1997, Trends in genetics : TIG.

[21]  E. Li,et al.  Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases , 1998, Nature Genetics.

[22]  A. Pombo,et al.  Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Higgs,et al.  Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome) , 1995, Cell.

[24]  S. Aftimos,et al.  Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain , 1997, Nature Genetics.

[25]  B. Howard,et al.  The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.

[26]  G. Seydoux,et al.  PIE-1 is a bifunctional protein that regulates maternal and zygotic gene expression in the embryonic germ line of Caenorhabditis elegans. , 2001, Genes & development.

[27]  R. Kuick,et al.  Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. , 2000, Human molecular genetics.

[28]  H. Masuya,et al.  Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[30]  M. J. Barratt,et al.  Phosphoacetylation of histone H3 on c‐fos‐ and c‐jun‐associated nucleosomes upon gene activation , 2000, The EMBO journal.

[31]  H. Zoghbi,et al.  Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes , 2000, Annals of neurology.

[32]  J. Stephenson,et al.  Rett's syndrome in the west of Scotland. , 1985, British medical journal.

[33]  V. Ingram,et al.  Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. , 1988, Journal of molecular biology.

[34]  S. Ishii,et al.  Drosophila CBP is a co-activator of cubitus interruptus in hedgehog signalling , 1997, Nature.

[35]  C. Ponting,et al.  Regulation of chromatin structure by site-specific histone H3 methyltransferases , 2000, Nature.

[36]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[37]  R. Meehan,et al.  Transient depletion of xDnmt1 leads to premature gene activation in Xenopus embryos. , 2000, Genes & development.

[38]  M. Johnston,et al.  Cognitive impairment in Coffin–Lowry syndrome correlates with reduced RSK2 activation , 2001, Neurology.

[39]  Juliet A. Ellis,et al.  The spatial organization of human chromosomes within the nuclei of normal and emerin-mutant cells. , 2001, Human molecular genetics.

[40]  A. Federico,et al.  MECP2 mutation in male patients with non‐specific X‐linked mental retardation , 2000, FEBS letters.

[41]  P. Pandolfi.  Transcription therapy for cancer , 2001, Oncogene.

[42]  E. Li,et al.  Cloning, expression and chromosome locations of the human DNMT3 gene family. , 1999, Gene.

[43]  J. Chelly,et al.  Parental origin of de novo MECP2 mutations in Rett syndrome , 2001, European Journal of Human Genetics.

[44]  A. Bird,et al.  Mammalian methyltransferases and methyl-CpG-binding domains: proteins involved in DNA methylation. , 2000, Current topics in microbiology and immunology.

[45]  A. Niveleau,et al.  Abnormal methylation pattern in constitutive and facultative (X inactive chromosome) heterochromatin of ICF patients. , 1994, Human molecular genetics.

[46]  T. Kakutani,et al.  Mobilization of transposons by a mutation abolishing full DNA methylation in Arabidopsis , 2001, Nature.

[47]  D. Higgs,et al.  A nonsense mutation of the ATRX gene causing mild mental retardation and epilepsy , 2000, Annals of neurology.

[48]  J. Fryns,et al.  A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. , 2000, American journal of human genetics.

[49]  H. Zoghbi,et al.  Patterns of X chromosome inactivation in the rett syndrome , 1990, Brain and Development.

[50]  U. Francke,et al.  A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map. , 1998, American journal of human genetics.

[51]  O. Delattre,et al.  Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. , 1999, American journal of human genetics.

[52]  P. Huppke,et al.  MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. , 2001, American journal of human genetics.

[53]  Raoul C. M. Hennekam,et al.  Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.

[54]  F. Ledeist,et al.  An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. , 1993, Human molecular genetics.

[55]  A. Graessmann,et al.  Inhibition of herpes simplex thymidine kinase gene expression by DNA methylation is an indirect effect. , 1985, Nucleic acids research.

[56]  C. Glass,et al.  Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. , 2001, Human molecular genetics.

[57]  P. Wade,et al.  Methyl CpG binding proteins: coupling chromatin architecture to gene regulation , 2001, Oncogene.

[58]  H. Ropers,et al.  MECP2 is highly mutated in X-linked mental retardation. , 2001, Human molecular genetics.

[59]  S. Baylin,et al.  Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to Heterochromatin* , 2001, The Journal of Biological Chemistry.

[60]  C. Schanen.  Rethinking the fate of males with mutations in the gene that causes Rett syndrome , 2001, Brain and Development.

[61]  R. Jaenisch,et al.  Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice , 2001, Nature Genetics.

[62]  R. Hennekam,et al.  Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations , 2000, Journal of medical genetics.

[63]  A. Wolffe,et al.  A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase , 1998, Current Biology.

[64]  A. Wolffe,et al.  Functional consequences of Rett syndrome mutations on human MeCP2. , 2000, Nucleic acids research.

[65]  Wei Gu,et al.  Synergistic activation of transcription by CBP and p53 , 1997, Nature.

[66]  C. Wijmenga,et al.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  M. J. Barratt,et al.  The nucleosomal response associated with immediate‐early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG‐14 kinase , 1999, The EMBO journal.

[68]  J. Millán,et al.  Mutation of the XNP/ATR-X gene in a family with severe mental retardation, spastic paraplegia and skewed pattern of X inactivation: demonstration that the mutation is involved in the inactivation bias. , 1999, American journal of human genetics.

[69]  S. Timsit,et al.  Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein. , 1998, Human molecular genetics.

[70]  E. Zackai,et al.  Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome , 1996, Nature.

[71]  D. Reinberg,et al.  The Dermatomyositis-Specific Autoantigen Mi2 Is a Component of a Complex Containing Histone Deacetylase and Nucleosome Remodeling Activities , 1998, Cell.

[72]  B. Hendrich.  Methylation moves into medicine. , 2000, Current biology : CB.

[73]  C. Allis,et al.  Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. , 1999, Science.

[74]  M. Breuning,et al.  Conjunction dysfunction: CBP/p300 in human disease. , 1998, Trends in genetics : TIG.

[75]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[76]  A. Bird,et al.  Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.

[77]  C. Schwartz,et al.  Mutations in the X‐linked RSK2 gene (RPS6KA3) in patients with Coffin‐Lowry syndrome , 2001, Human mutation.

[78]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[79]  A. Wolffe,et al.  Acetylation of general transcription factors by histone acetyltransferases , 1997, Current Biology.

[80]  A. Munnich,et al.  XNP mutation in a large family with Juberg-Marsidi syndrome , 1996, Nature Genetics.

[81]  B. Hendrich.  Human genetics: Methylation moves into medicine , 2000, Current Biology.

[82]  H. Leonard,et al.  Occurrence of Rett Syndrome in Boys , 2001, Journal of child neurology.

[83]  A. Bird,et al.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome , 2001, Nature Genetics.

[84]  C. Allis,et al.  Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. , 2000, Molecular cell.

[85]  A. Bird,et al.  DNA Recognition by the Methyl-CpG Binding Domain of MeCP2* , 2001, The Journal of Biological Chemistry.

[86]  J. Clayton-Smith,et al.  Angelman syndrome phenotype associated with mutations inMECP2, a gene encoding a methyl CpG binding protein , 2001, Journal of medical genetics.

[87]  Andrew J. Bannister,et al.  The CBP co-activator is a histone acetyltransferase , 1996, Nature.

[88]  Reduced DNA methylation in Arabidopsis thaliana results in abnormal plant development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[89]  Olivier Delattre,et al.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.

[90]  D. Higgs,et al.  Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation , 2000, Nature Genetics.

[91]  C. Roberts,et al.  Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[92]  Q. Feng,et al.  The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. , 2001, Genes & development.

[93]  A. Bird,et al.  MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.

[94]  Pier Giuseppe Pelicci,et al.  Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? , 2001, Oncogene.

[95]  Julian Downward,et al.  EGF induced SOS phosphorylation in PC12 cells involves P90 RSK-2 , 1997, Oncogene.

[96]  A. Bird,et al.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA , 1992, Cell.

[97]  D. Higgs,et al.  ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. , 1996, Human molecular genetics.

[98]  M. D'Esposito,et al.  A synaptobrevin–like gene in the Xq28 pseudoautosomal region undergoes X inactivation , 1996, Nature Genetics.

[99]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[100]  J. Gécz,et al.  Identification of a mutation in the XNP/ATR-X gene in a family reported as Smith-Fineman-Myers syndrome. , 2000, American journal of medical genetics.

[101]  C. Wijmenga,et al.  Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant. , 2000, Human molecular genetics.

[102]  D. Armstrong,et al.  The Neuropathology of Rett Syndrome - Overview 1994 , 1995, Neuropediatrics.

[103]  M. Stacey,et al.  FISH analysis on spontaneously arising micronuclei in the ICF syndrome. , 1995, Journal of medical genetics.